TrialCancer chemotherapy and pharmacology2016

Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer.

Benjamin L Maughan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.